Trial Profile
Investigation of epiphora caused by rebamipide eyedrop
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 24 Sep 2021
Price :
$35
*
At a glance
- Drugs Rebamipide (Primary)
- Indications Epiphora
- Focus Adverse reactions
- 07 Apr 2015 New trial record